港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

晶泰控股-P

4.640

+0.0100.22%

成交量：3,427.36万

成交额：1.60亿

市值：186.53亿

市盈率：-5.48

高：4.780

开：4.710

低：4.600

收：4.630

数据加载中...

总览公司新闻资讯公告

晶泰控股-P(02228)拟发行最多3.42亿股配售股份净筹20.8亿港元

【晶泰控股-P(02228.HK)与广东恒健积极推进“人工智能+”科技与产业融合创新联合体项目的落地】晶泰控股-P(02228.HK)发布公告，近日，本公司全资附属公司深圳晶泰科技有限公司与广东恒健投资控股有限公司(广东恒健)正积极推进“人工智能+”科技与产业融合创新联合体项目(该项目)的落地，该项目以“AI+机器人自动化”技术为核心，致力于建设全球领先的研发创新基础设施与产业孵化生态系统，促进战略性产业集群化发展，推动粤港澳大湾区及全球相关产业加速实现数字化和智能化革新，助力大湾区打造世界一流的人工智能研究基础设施，驱动AI医药、新材料、新能源、机器人等产业的未来发展。

晶泰控股-P02月18日主力净流出5190万元散户资金买入

晶泰控股－Ｐ(02228)出现大手卖出110万股，成交价$6.5，涉资715万

阿斯达克财经

晶泰控股-P(02228)下跌5.11%，报6.5元/股

晶泰控股-P盘中异动快速下挫5.11%报6.500港元

【默达生物获上亿元人民币A轮融资】深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。

港股异动 | 晶泰控股-P(02228)早盘涨超3% 预期2024年度将达到已商业化公司的收入门槛

招商证券：AI制药蓝海人工智能助力新药开发全流程

晶泰控股-P02月17日收涨3.63% 主力资金逆市抛售

晶泰控股：2024 年营收预期达 2.5 亿港元

晶泰控股预计2024年收入达2.5亿港元

晶泰控股-P预期2024年度将达到已商业化公司的收入门槛

晶泰控股(02228.HK)料去年药物发现及智能自动化解决方案收入达商业化公司收入门槛

阿斯达克财经

晶泰控股-P(02228)预期2024年度将达到已商业化公司的收入门槛

晶泰控股-P02月14日主力大幅流入1.02亿元散户资金抛售

【港股异动 | 晶泰控股-P(02228.HK)午后涨超9%】晶泰控股-P(02228.HK)午后涨超9%，截至发稿，涨7.11%，报6.48港元，成交额10.34亿港元。

港股异动 | 晶泰控股-P(02228)午后涨超9% AI制药潜力巨大公司近期与韩国药企JW达成战略合作

“AI+医疗”概念火热并获多方看好相关股份集体走高医渡科技(02158)涨10.38%

异动解读 | 晶泰控股盘中大涨5.12% 或因AI驱动医疗健康板块新机遇

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02228/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02228","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股-P","latestPrice":4.64,"timestamp":1747021414128,"preClose":4.63,"halted":0,"volume":34273569,"delay":0,"floatShares":4020000000,"shares":4020000000,"eps":-0.8471152356551951,"marketStatus":"交易中","change":0.01,"latestTime":"05-12 11:43:37","open":4.71,"high":4.78,"low":4.6,"amount":160132441,"amplitude":0.038877,"askPrice":4.64,"askSize":110000,"bidPrice":4.63,"bidSize":395000,"shortable":3,"etf":0,"ttmEps":-0.8513850935547698,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1747022400000},"marketStatusCode":2,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":4.63,"openAndCloseTimeList":[[1747013400000,1747022400000],[1747026000000,1747036800000]],"volumeRatio":1.556492,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","floatShares":4020000000,"roa":"-10.69%","roe":"--","lyrEps":-0.847115,"volumeRatio":1.556492,"shares":4020000000,"dividePrice":0,"high":4.78,"amplitude":0.038877,"preClose":4.63,"low":4.6,"week52Low":3.05,"pbRate":"4.37","psRate":"64.96","week52High":16.2,"institutionHeld":0,"latestPrice":4.64,"committee":0.564356,"eps":-0.8471152356551951,"divideRate":0,"volume":34273569,"delay":0,"ttmEps":-0.8513850935547698,"open":4.71,"prevYearClose":5.98,"prevWeekClose":4.63,"prevMonthClose":5.16,"prevQuarterClose":5.89,"fiveDayClose":5.11,"twentyDayClose":4.16,"sixtyDayClose":6.74},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02228\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512719119","title":"晶泰控股-P(02228)拟发行最多3.42亿股配售股份 净筹20.8亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512719119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512719119?lang=zh_cn&edition=fundamental","pubTime":"2025-02-19 07:49","pubTimestamp":1739922580,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股-P 发布公告，于2025年2月19日，本公司与配售代理订立配售协议，本公司同意根据一般授权发行，而配售代理同意作为本公司的代理，在配售协议的条款及条件规限下，按尽力基准促使承配人按配售价每股配售股份6.10港元认购合共最多3.42亿股配售股份。假设所有3.42亿股配售股份获悉数认购，于完成后，配售将筹集的所得款项总额将约为20.88亿港元，而配售产生的所得款项净额估计约为20.8亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1251409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","02228"],"gpt_icon":1},{"id":"2512111511","title":"【晶泰控股-P(02228.HK)与广东恒健积极推进“人工智能+”科技与产业融合创新联合体项目的落地】晶泰控股-P(02228.HK)发布公告，近日，本公司全资附属公司深圳晶泰科技有限公司与广东恒健投资控股有限公司(广东恒健)正积极推进“人工智能+”科技与产业融合创新联合体项目(该项目)的落地，该项目以“AI+机器人自动化”技术为核心，致力于建设全球领先的研发创新基础设施与产业孵化生态系统，促进战略性产业集群化发展，推动粤港澳大湾区及全球相关产业加速实现数字化和智能化革新，助力大湾区打造世界一流的人工智能研究基础设施，驱动AI医药、新材料、新能源、机器人等产业的未来发展。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111511","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512111511?lang=zh_cn&edition=fundamental","pubTime":"2025-02-19 07:48","pubTimestamp":1739922504,"startTime":"0","endTime":"0","summary":"晶泰控股-P(02228.HK)发布公告，近日，本公司全资附属公司深圳晶泰科技有限公司与广东恒健投资控股有限公司(广东恒健)正积极推进“人工智能+”科技与产业融合创新联合体项目(该项目)的落地，该项目以“AI+机器人自动化”技术为核心，致力于建设全球领先的研发创新基础设施与产业孵化生态系统，促进战略性产业集群化发展，推动粤港澳大湾区及全球相关产业加速实现数字化和智能化革新，助力大湾区打造世界一流的人工智能研究基础设施，驱动AI医药、新材料、新能源、机器人等产业的未来发展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19074848243779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","02228","000941.SH","159983","161631","399941","BK1161","160640","159875","09939","159703","159938","BK1515","BK1141"],"gpt_icon":0},{"id":"2512813513","title":"晶泰控股-P02月18日主力净流出5190万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2512813513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512813513?lang=zh_cn&edition=fundamental","pubTime":"2025-02-18 16:16","pubTimestamp":1739866597,"startTime":"0","endTime":"0","summary":"02月18日, 晶泰控股-P股价跌5.40%，报收6.48元，成交金额11.89亿元，换手率4.82%，振幅12.55%，量比0.91。晶泰控股-P今日主力资金净流出5190万元，上一交易日主力净流出7084万元。该股近5个交易日下跌3.28%，主力资金累计净流出1.23亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1.07亿元，其中净流入天数为10日。该股主力净额占比0.22%，港股市场排名2624/2650。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218161724a24a46bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218161724a24a46bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141"],"gpt_icon":1},{"id":"2512189707","title":"晶泰控股－Ｐ(02228)出现大手卖出110万股，成交价$6.5，涉资715万","url":"https://stock-news.laohu8.com/highlight/detail?id=2512189707","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512189707?lang=zh_cn&edition=fundamental","pubTime":"2025-02-18 13:55","pubTimestamp":1739858100,"startTime":"0","endTime":"0","summary":"[大手成交]晶泰控股－Ｐ(02228)在下午01:55出现大手卖出，成交量为110万，成交价为港币$6.5，涉资715万。至目前为止，股价跌5.109%，今日最高价为$7.14，而最低价为$6.5，总成交量为1.221亿股，总成交金额港币$8.353亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2502189001/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2512166186","title":"晶泰控股-P(02228)下跌5.11%，报6.5元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166186","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512166186?lang=zh_cn&edition=fundamental","pubTime":"2025-02-18 13:38","pubTimestamp":1739857124,"startTime":"0","endTime":"0","summary":"2月18日，晶泰控股-P(02228)盘中下跌5.11%，截至13:38，报6.5元/股，成交7.88亿元。晶泰控股有限公司主要以量子物理、人工智能和机器人技术为基础，为全球制药、材料科学等领域提供研发解决方案及服务。公司运用量子物理原理、先进的AI技术、高性能云计算以及可扩展和标准化的机器人自动化等技术，服务于农业技术、能源、新型化学品以及化妆品等行业。截至2024年中报，晶泰控股-P营业总收入1.03亿元、净利润-12.37亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/18133848221643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"2512148186","title":"晶泰控股-P盘中异动 快速下挫5.11%报6.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512148186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512148186?lang=zh_cn&edition=fundamental","pubTime":"2025-02-18 13:37","pubTimestamp":1739857022,"startTime":"0","endTime":"0","summary":"2025年02月18日下午盘13时37分，晶泰控股-P股票出现波动，股价急速下跌5.11%。截至发稿，该股报6.500港元/股，成交量1.12554亿股，换手率3.06%，振幅9.34%。资金方面，该股资金流入2.87112亿港元，流出3.5994亿港元。晶泰控股-P股票所在的生物技术行业中，整体涨幅为1.15%。该信息摘要如下： 晶泰控股-P 发布公告称，集团预计截至 2024 年 12 月 31 日止年度，通过提供药物发现解决方案及智能自动化解决方案产生的收入能达到 2.5 亿港元这一已商业化公司的收入门槛。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021813370296271014&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021813370296271014&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141"],"gpt_icon":1},{"id":"2512249902","title":"【默达生物获上亿元人民币A轮融资】深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512249902","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512249902?lang=zh_cn&edition=fundamental","pubTime":"2025-02-18 11:23","pubTimestamp":1739849027,"startTime":"0","endTime":"0","summary":"深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/18112348218626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1066051498.USD","LU1127390331.HKD","LU0878866978.SGD","LU0553294199.USD","LU0949170772.SGD","LU0545039389.USD","LU0985320562.USD","IE00BK4W5M84.HKD","IE00B7KXQ091.USD","IE00BJTD4V19.USD","LU2430703251.USD","LU0795875169.SGD","LU2213496289.HKD","SG9999014898.SGD","LU0353189680.USD","02228","IMO","LU0097036916.USD","LU0011850046.USD","LU1868837136.USD","LU2462157665.USD","LU0354030511.USD","LU0082616367.USD","LU2764262908.HKD","LU0109391861.USD","300832","SGXZ99366536.SGD","LU0225283273.USD","IE00B4JS1V06.HKD","BK0239","SGXZ31699556.SGD","LU1642822529.SGD","LU0234572021.USD","LU0912757837.SGD","LU2133065610.SGD","LU1852331112.SGD","LU1988902786.USD","LU1778281490.HKD","159837","LU1201861249.SGD","LU1242518931.SGD","BK4592","GB00B4QBRK32.GBP","LU0345769128.USD","LU2720916845.USD","LU1814569148.SGD","LU0157215616.USD","LU1732799900.SGD","LU0061475181.USD"],"gpt_icon":0},{"id":"2512901346","title":"港股异动 | 晶泰控股-P(02228)早盘涨超3% 预期2024年度将达到已商业化公司的收入门槛","url":"https://stock-news.laohu8.com/highlight/detail?id=2512901346","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512901346?lang=zh_cn&edition=fundamental","pubTime":"2025-02-18 10:35","pubTimestamp":1739846117,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，晶泰控股-P(02228)早盘涨超3%，截至发稿，涨3.65%，报7.1港元，成交额3.2亿港元。消息面上，晶泰控股-P发布公告，集团预期截至2024年12月31日止年度透过提供药物发现解决方案及智能自动化解决方案所产生的收入将达到已商业化公司(定义见上市规则第18C章)的收入门槛，即2.5亿港元。该等收入乃由于本集团于截至2024年12月31日止年度的业务发展及市场机遇所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1250980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2512912788","title":"招商证券：AI制药蓝海 人工智能助力新药开发全流程","url":"https://stock-news.laohu8.com/highlight/detail?id=2512912788","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512912788?lang=zh_cn&edition=fundamental","pubTime":"2025-02-17 16:47","pubTimestamp":1739782033,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招商证券发布研报称，目前人工智能技术在药物研发过程中的应用主要集中于药物发现阶段，随着Deepseek等大模型技术应用，AI在临床阶段的应用价值也将逐渐得到体现。招商证券主要观点如下：AI可用于新药开发全过程，达到降低成本，增加药物研发可能性目的。全球AI制药行业投融资活跃，MNC 参与达成多项重磅交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1250656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06099","BK0028","BK0188","01873","01477","BK0012","02228","03759","BK0010","BK0276","BK0183","BK1576","BK1574","161631","BK1191","BK1147","BK1141","600999","BK1564"],"gpt_icon":1},{"id":"2512114729","title":"晶泰控股-P02月17日收涨3.63% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2512114729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512114729?lang=zh_cn&edition=fundamental","pubTime":"2025-02-17 16:17","pubTimestamp":1739780223,"startTime":"0","endTime":"0","summary":"02月17日, 晶泰控股-P股价涨3.63%，报收6.85元，成交金额13.37亿元，换手率5.36%，振幅10.44%，量比0.91。晶泰控股-P今日主力资金净流出7084万元，上一交易日主力净流入1.02亿元。该股近5个交易日上涨1.48%，主力资金累计净流出1.37亿元；近20日主力资金累计净流入1.58亿元，其中净流入天数为10日。该股主力净额占比0.28%，港股市场排名2635/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217161813a248ebd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217161813a248ebd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228"],"gpt_icon":1},{"id":"2512225967","title":"晶泰控股：2024 年营收预期达 2.5 亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512225967","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512225967?lang=zh_cn&edition=fundamental","pubTime":"2025-02-17 09:54","pubTimestamp":1739757285,"startTime":"0","endTime":"0","summary":"【晶泰控股-P 预期 2024 年年度收入将达 2.5 亿港元】 晶泰控股-P 发布公告称，集团预计截至 2024 年 12 月 31 日止年度，通过提供药物发现解决方案及智能自动化解决方案产生的收入能达到 2.5 亿港元这一已商业化公司的收入门槛。 这一收入是由于集团在截至 2024 年 12 月 31 日止年度的业务发展及市场机遇所致。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217100526988808f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217100526988808f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228"],"gpt_icon":0},{"id":"2512964957","title":"晶泰控股预计2024年收入达2.5亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512964957","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512964957?lang=zh_cn&edition=fundamental","pubTime":"2025-02-17 09:35","pubTimestamp":1739756153,"startTime":"0","endTime":"0","summary":"晶泰控股-P（02228）发布公告，预计截至2024年12月31日止年度，通过提供药物发现解决方案及智能自动化解决方案所产生的收入将达到2.5亿港元。这一预期收入的增长主要得益于公司在业务发展及市场机遇方面的良好表现。公告中提到的收入数据基于公司管理层的初步评估，尚未经过审计，实际业绩可能会有所不同。此外，公告指出，截止目前，公司仍被视为尚未商业化公司。若未来获得联交所通知不再被视为尚未商业化公司，晶泰控股将会适时发布进一步公告。投资者在交易公司证券时需保持谨慎，关注未来的业绩发布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021709361296259c20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021709361296259c20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"2512966004","title":"晶泰控股-P预期2024年度将达到已商业化公司的收入门槛","url":"https://stock-news.laohu8.com/highlight/detail?id=2512966004","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512966004?lang=zh_cn&edition=fundamental","pubTime":"2025-02-17 08:44","pubTimestamp":1739753040,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　晶泰控股-P（02228）发布公告，集团预期截至2024年12月31日止年度透过提供药物发现解决方案及智能自动化解决方案所产生的收入将达到已商业化公司（定义见上市规则第18C章）的收入门槛，即2.5亿港元。该等收入乃由于本集团于截至2024年12月31日止年度的业务发展及市场机遇所致。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-17/doc-inektywp5001930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"2512694489","title":"晶泰控股(02228.HK)料去年药物发现及智能自动化解决方案收入达商业化公司收入门槛","url":"https://stock-news.laohu8.com/highlight/detail?id=2512694489","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512694489?lang=zh_cn&edition=fundamental","pubTime":"2025-02-17 08:34","pubTimestamp":1739752440,"startTime":"0","endTime":"0","summary":"晶泰控股-P(02228.HK) 公布，预期去年透过提供药物发现解决方案及智能自动化解决方案所产生的收入，将达到已商业化公司的收入门槛，即2.5亿元，乃由于集团去年业务发展及市场机遇所致。(jl/da)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-14 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240611135701030_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240611135701030_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1417643/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2512921965","title":"晶泰控股-P(02228)预期2024年度将达到已商业化公司的收入门槛","url":"https://stock-news.laohu8.com/highlight/detail?id=2512921965","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512921965?lang=zh_cn&edition=fundamental","pubTime":"2025-02-17 08:04","pubTimestamp":1739750670,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股-P(02228)发布公告，集团预期截至2024年12月31日止年度透过提供药物发现解决方案及智能自动化解决方案所产生的收入将达到已商业化公司(定义见上市规则第18C章)的收入门槛，即2.5亿港元。该等收入乃由于本集团于截至2024年12月31日止年度的业务发展及市场机遇所致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1250411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2511656700","title":"晶泰控股-P02月14日主力大幅流入1.02亿元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2511656700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511656700?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 16:17","pubTimestamp":1739521035,"startTime":"0","endTime":"0","summary":"02月14日, 晶泰控股-P股价涨9.26%，报收6.61元，成交金额16.91亿元，换手率7.07%，振幅13.55%，量比1.35。晶泰控股-P今日主力资金净流入1.02亿元，上一交易日主力净流出9294万元。该股近5个交易日上涨9.64%，主力资金累计净流入6448万元；近20日主力资金累计净流入2.27亿元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214161850a2459cc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214161850a2459cc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228"],"gpt_icon":1},{"id":"2511639994","title":"【港股异动 | 晶泰控股-P(02228.HK)午后涨超9%】晶泰控股-P(02228.HK)午后涨超9%，截至发稿，涨7.11%，报6.48港元，成交额10.34亿港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511639994","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511639994?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 14:11","pubTimestamp":1739513494,"startTime":"0","endTime":"0","summary":"晶泰控股-P(02228.HK)午后涨超9%，截至发稿，涨7.11%，报6.48港元，成交额10.34亿港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14141148160619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2511586639","title":"港股异动 | 晶泰控股-P(02228)午后涨超9% AI制药潜力巨大 公司近期与韩国药企JW达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2511586639","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511586639?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 14:08","pubTimestamp":1739513301,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，晶泰控股-P午后涨超9%，截至发稿，涨7.11%，报6.48港元，成交额10.34亿港元。建议关注AI制药，如晶泰控股-P等。此外，晶泰科技近期宣布，与亚洲领先的韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。此次与JW的合作，标志着晶泰科技自动化实验室解决方案首次获得海外药企客户的采购，具有重要的里程碑意义。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249827.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","BK1141","02228","01477"],"gpt_icon":1},{"id":"2511686533","title":"“AI+医疗”概念火热并获多方看好 相关股份集体走高 医渡科技(02158)涨10.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511686533","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511686533?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 09:52","pubTimestamp":1739497955,"startTime":"0","endTime":"0","summary":"金吾财讯 | “AI+医疗”概念火热，医渡科技 涨10.38%，信达生物涨5.3%，晶泰控股涨3.97%，讯飞医疗科技涨3.07%，鹰瞳科技跟涨。交银国际表示，AI大模型赋能数字医疗服务公司，在疾病诊断/检测方面潜力显着。另外，高盛此前在2025年国际消费类电子产品展览会数字医疗健康专场中，即点明“AI+医疗”将成为该行业吸引全球资金最核心的投资主题。","market":"sg","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953143","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","BK1141","BK1589","159891","02228","LU1969619763.USD","BK1161","LU2328871848.SGD","02158","02506","BK1189","02251","LU2488822045.USD","BK1518","BK1583"],"gpt_icon":0},{"id":"1127190908","title":"异动解读 | 晶泰控股盘中大涨5.12% 或因AI驱动医疗健康板块新机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1127190908","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127190908?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 09:42","pubTimestamp":1739497374,"startTime":"0","endTime":"0","summary":"今日盘中,晶泰控股(02228)股价大涨5.12%,引发了市场的广泛关注。\n\n据相关报道,交银国际指出,多家医药公司接入DeepSeek AI模型,AI加医疗加速落地。消费级医疗健康公司如晶泰控股所属的医渡科技(02158)等宣布接入DeepSeek模型,有望在疾病诊断、电子病历等领域获得AI赋能,提升服务效率。同时,AI大模型也可助力医药研发,提高药物设计效率,利好创新药企和CRO公司。\n\n交银国际预计,在财政和医保利好政策的持续利好下,医药健康板块整体仍有较大估值修复空间,建议重点关注拥有AI应用场景优势的相关公司,如医渡科技、晶泰控股等。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 晶泰控股盘中大涨5.12% 或因AI驱动医疗健康板块新机遇","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02228\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02228\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02228\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1742313600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02228\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02228","date":"2025-05-09","current":-8.545306,"percent":0.61086,"low":-19.121462,"twenty":-11.391935,"median":-8.912474,"eighty":-6.740034,"high":-4.071689,"avg":-9.343687,"sd":2.977588,"marketCap":18611728453},"quantilePoints":[{"date":"2024-06-14","current":-8.922014,"twenty":-9.439723,"median":-9.245582,"eighty":-9.051441,"marketCap":18396572909},{"date":"2024-06-21","current":-8.857946,"twenty":-8.9092,"median":-8.775161,"eighty":-8.737522,"marketCap":18226234271},{"date":"2024-06-28","current":-8.745676,"twenty":-8.918198,"median":-8.816527,"eighty":-8.750223,"marketCap":17987760178},{"date":"2024-07-05","current":-8.747576,"twenty":-8.902934,"median":-8.771787,"eighty":-8.744343,"marketCap":17987760178},{"date":"2024-07-12","current":-9.049063,"twenty":-8.902934,"median":-8.775161,"eighty":-8.741587,"marketCap":18635047002},{"date":"2024-07-19","current":-9.247407,"twenty":-9.172529,"median":-8.857489,"eighty":-8.744343,"marketCap":19043859733},{"date":"2024-07-26","current":-9.575773,"twenty":-9.510189,"median":-8.892407,"eighty":-8.745676,"marketCap":19793349741},{"date":"2024-08-02","current":-9.235042,"twenty":-9.509847,"median":-8.912474,"eighty":-8.745676,"marketCap":19077927461},{"date":"2024-08-09","current":-9.468775,"twenty":-9.510189,"median":-8.974725,"eighty":-8.747576,"marketCap":19691146558},{"date":"2024-08-16","current":-10.464009,"twenty":-9.56947,"median":-9.142341,"eighty":-8.760904,"marketCap":21769277942},{"date":"2024-08-23","current":-10.517808,"twenty":-9.632925,"median":-9.235042,"eighty":-8.768412,"marketCap":21973684308},{"date":"2024-08-30","current":-10.371399,"twenty":-10.303269,"median":-9.325095,"eighty":-8.775161,"marketCap":28923500740},{"date":"2024-09-06","current":-18.461728,"twenty":-10.496901,"median":-9.468775,"eighty":-8.776023,"marketCap":51510404146},{"date":"2024-09-13","current":-17.236995,"twenty":-10.891661,"median":-9.521964,"eighty":-8.857032,"marketCap":47967360474},{"date":"2024-09-20","current":-16.063353,"twenty":-11.51195,"median":-9.559061,"eighty":-8.857763,"marketCap":44969400445},{"date":"2024-09-27","current":-15.483466,"twenty":-14.686278,"median":-9.575773,"eighty":-8.860072,"marketCap":43606691340},{"date":"2024-10-04","current":-13.755671,"twenty":-14.947547,"median":-9.615329,"eighty":-8.879685,"marketCap":38564667654},{"date":"2024-10-10","current":-12.348216,"twenty":-14.780027,"median":-9.846626,"eighty":-8.896618,"marketCap":34408404886},{"date":"2024-10-18","current":-11.446606,"twenty":-14.586898,"median":-10.272952,"eighty":-8.910566,"marketCap":31717054404},{"date":"2024-10-25","current":-12.086709,"twenty":-14.247622,"median":-10.371399,"eighty":-8.935918,"marketCap":33488576240},{"date":"2024-11-01","current":-11.046421,"twenty":-13.547793,"median":-10.507354,"eighty":-8.963954,"marketCap":30626887121},{"date":"2024-11-08","current":-8.233542,"twenty":-13.084166,"median":-10.464009,"eighty":-8.959678,"marketCap":22655038860},{"date":"2024-11-15","current":-6.674421,"twenty":-12.818197,"median":-10.331022,"eighty":-8.873325,"marketCap":18226234271},{"date":"2024-11-22","current":-5.092957,"twenty":-12.605094,"median":-9.956054,"eighty":-8.775506,"marketCap":13899632864},{"date":"2024-11-29","current":-4.071689,"twenty":-12.362191,"median":-9.633447,"eighty":-8.746436,"marketCap":11106079200},{"date":"2024-12-06","current":-6.234627,"twenty":-12.309524,"median":-9.607633,"eighty":-8.729287,"marketCap":16965728349},{"date":"2024-12-13","current":-4.937116,"twenty":-12.241743,"median":-9.572622,"eighty":-8.309283,"marketCap":13422684678},{"date":"2024-12-20","current":-6.992956,"twenty":-12.176011,"median":-9.548971,"eighty":-7.374004,"marketCap":18907588823},{"date":"2024-12-27","current":-7.61626,"twenty":-12.099333,"median":-9.521964,"eighty":-6.992956,"marketCap":20576907476},{"date":"2025-01-03","current":-6.613619,"twenty":-12.089234,"median":-9.489311,"eighty":-6.978437,"marketCap":17885556995},{"date":"2025-01-10","current":-5.450117,"twenty":-12.058756,"median":-9.391379,"eighty":-6.644107,"marketCap":14683190599},{"date":"2025-01-17","current":-5.875315,"twenty":-12.04248,"median":-9.241225,"eighty":-6.25569,"marketCap":15841493338},{"date":"2025-01-24","current":-6.177753,"twenty":-11.949888,"median":-9.172529,"eighty":-6.11967,"marketCap":16761321984},{"date":"2025-01-28","current":-6.498305,"twenty":-11.921589,"median":-9.112153,"eighty":-6.130311,"marketCap":17715218357},{"date":"2025-02-07","current":-7.424154,"twenty":-11.872333,"median":-8.96938,"eighty":-6.148709,"marketCap":20134027017},{"date":"2025-02-14","current":-8.323374,"twenty":-11.760531,"median":-8.922014,"eighty":-6.178085,"marketCap":22518767950},{"date":"2025-02-21","current":-10.607329,"twenty":-11.720414,"median":-8.939394,"eighty":-6.187416,"marketCap":28855365285},{"date":"2025-02-28","current":-8.380735,"twenty":-11.643652,"median":-8.964036,"eighty":-6.222464,"marketCap":22723174315},{"date":"2025-03-07","current":-8.409794,"twenty":-11.556185,"median":-8.912474,"eighty":-6.239893,"marketCap":22893512953},{"date":"2025-03-14","current":-8.131514,"twenty":-11.5122,"median":-8.860603,"eighty":-6.269085,"marketCap":22144022946},{"date":"2025-03-21","current":-7.997044,"twenty":-11.440339,"median":-8.816527,"eighty":-6.340941,"marketCap":21769277942},{"date":"2025-03-28","current":-9.307254,"twenty":-11.391935,"median":-8.776023,"eighty":-6.503525,"marketCap":25284615976},{"date":"2025-04-03","current":-13.220486,"twenty":-11.563082,"median":-8.857032,"eighty":-6.524404,"marketCap":21465794803},{"date":"2025-04-11","current":-11.616184,"twenty":-11.563082,"median":-8.876505,"eighty":-6.613619,"marketCap":18692124688},{"date":"2025-04-17","current":-8.481901,"twenty":-11.535495,"median":-8.876505,"eighty":-6.644107,"marketCap":18290143512},{"date":"2025-04-25","current":-9.200975,"twenty":-11.479403,"median":-8.897671,"eighty":-6.665344,"marketCap":19857870099},{"date":"2025-05-02","current":-9.49742,"twenty":-11.434072,"median":-8.939394,"eighty":-6.691701,"marketCap":20541238098},{"date":"2025-05-09","current":-8.545306,"twenty":-11.391935,"median":-8.912474,"eighty":-6.740034,"marketCap":18611728453}],"updateTime":1747021417328}}}